TIVC Tivic Health Systems, Inc. logo

TIVC Tivic Health Systems, Inc.

Healthcare
$0.88+0.46%ClosedMarket Cap: $952,183

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.23

P/S

-13.60

EV/EBITDA

-0.32

DCF Value

$-2.58

FCF Yield

-1177.5%

Div Yield

0.0%

Margins & Returns

Gross Margin

561.4%

Operating Margin

17180.0%

Net Margin

19397.1%

ROE

-146.2%

ROA

-35.5%

ROIC

-33.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$0.00$-6.2M$
Q4 null$-302.0K$-2.8M$
FY null$382.0K$-8.9M$
Q3 null$146.0K$-2.6M$

Analyst Ratings

View All

Consensus

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Bolton Sheryledirector
BuyMon Apr 20
Valauri Christina Rizopoulosdirector
BuyThu Apr 02
Wolf Lisa Gofficer: Chief Financial Officer
SellThu Mar 19
Handley Michael Kofficer: Chief Operating Officer
SellFri Feb 20
Wolf Lisa Gofficer: Chief Financial Officer
SellMon Dec 22

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

1.84

Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Peers